Mounjaro or Weight Loss Peptides in 2026 — What to Choose and Why Combination is Optimal

When it comes to choosing between Mounjaro and peptide therapy, most people seek an answer to the question "what's better". And here's the truth that's rarely spoken: these are different tools for different tasks. And the best result often comes from their combination.

Mounjaro and peptides are not competitors. Mounjaro quickly blocks appetite and provides minus 22.5% weight loss in 72 weeks [12]. Peptides work more slowly but correct metabolism at a deeper level: MOTS-c activates mitochondria, 5-Amino-1MQ removes the "brake" on fat metabolism, BPC-157 protects the gastrointestinal tract from side effects of GLP-1 agonists. The optimal strategy for 2026 — Mounjaro for a quick start, peptides for sustainable results.

In brief: how do Mounjaro and peptides fundamentally differ?

If explaining as simply as possible: Mounjaro is a "fast lever" for weight loss. Tirzepatide, Mounjaro's active substance, acts through dual mechanism of GLP-1 and GIP receptor activation. Result — rapid and powerful appetite suppression, slowed gastric emptying, 16-22.5% weight loss depending on dose [11].

Peptides — a different story. They don't block appetite directly. Instead they influence metabolic processes: mitochondrial function, fat metabolism, tissue regeneration, body's stress response. Effect is slower but "deeper". And importantly — peptides don't cause plateau effect as often as GLP-1 agonists.

Honestly speaking, for most people with BMI over 30, Mounjaro will be the better start. But if the goal is not just to lose weight, but to maintain results and improve overall metabolic state, one should think about a comprehensive approach.

Mounjaro: mechanism of action and real results

Tirzepatide is a dual GLP-1 and GIP receptor agonist. FDA approved it for improved glycemic control in type 2 diabetes (under the name Mounjaro) and for chronic weight management (under the name Zepbound) [3]. In Ukraine, original Mounjaro manufactured by Eli Lilly UK is available.

What did the largest SURMOUNT-1 study show? It included 2,539 people with obesity or overweight but without diabetes [18]. Results impressed even skeptics:

On 10 mg dose, participants lost an average of 21.4% weight, on 5 mg — 16% [11]. For comparison: placebo group lost only 2.4%. The difference is colossal.

Dosing starts at 2.5 mg weekly, then gradually increases every 4 weeks up to maximum 15 mg [8]. This approach minimizes side effects, although avoiding them completely doesn't succeed for everyone.

Mounjaro side effects: what to expect?

Most common side effects are gastrointestinal. In SURMOUNT-1 study, nausea was observed in 24.6-33.3% of participants depending on dose, diarrhea — in 18.7-23%, constipation — in 11.7-17.1% [12]. Most of these reactions were mild or moderate and occurred mainly during dose titration.

Important point: percentage of therapy discontinuation due to side effects was 4.3-7.1% depending on dose [12]. This means over 90% of people continue taking Mounjaro despite discomfort. And from DOZA experience, proper preparation and specialist support significantly reduce even these numbers.

The price corresponds to the original Made in UK product with full specialist support. In the DOZA catalog, you can choose the required dose and get a free consultation before ordering.

Weight loss peptides: different mechanism, different goals

Peptides are short chains of amino acids that act as signaling molecules in the body [4]. Unlike GLP-1 agonists, they don't block appetite directly. Instead they influence metabolism, tissue regeneration, mitochondrial function.

Here are key peptides used to support weight and metabolism:

MOTS-c — mitochondrial peptide that improves glucose utilization by cells. Researcher Pinchas Cohen founded a company to conduct phase I clinical trials of MOTS-c. The peptide showed safety, though caused skin irritation [4]. Human studies are still limited, but the mechanism of action is promising.

BPC-157 — a 15 amino acid peptide that in preclinical studies on rodents showed reduction in body fat percentage and increase in muscle mass [27]. It also demonstrated potential for GI tract protection — which is especially interesting in the context of GLP-1 agonist side effects.

Ipamorelin and CJC-1295 — peptides that stimulate growth hormone release. Used to maintain muscle mass, especially after 35-40 years when natural GH decline accelerates.

However, FDA recently updated its position. BPC-157 will be removed from Category 2 after seven calendar days [24]. The regulatory situation is changing, and this is important to track.

Note: this is not an "either-or" question. For many people, the combination will be optimal — start with Mounjaro, then switch to peptides to maintain results.

When to choose Mounjaro?

Mounjaro is the best choice if:

• BMI 30 and above — with significant overweight, powerful GLP-1+GIP agonist gives the fastest start. SURMOUNT-1 study showed best results exactly in this group [18].
• Need rapid results — wedding in 6 months, surgery in half a year, another important event. Mounjaro gives visible results in just 4-8 weeks.
• Type 2 diabetes — FDA approved tirzepatide specifically for improving glycemic control [6]. If combining weight loss with blood sugar control, this is the optimal choice.
• Previous failed attempts — if diets, fitness, Ozempic didn't give results, Mounjaro often becomes the "breakthrough". Dual GLP-1+GIP mechanism is more effective than mono-agonists [19].
• Readiness for side effects — you understand that first weeks may have discomfort, and ready to go through this period under specialist supervision.

Important: Mounjaro is not a "magic pill". Without correction of eating habits and physical activity, the result will be less. But with the right approach, according to the DOZA program, clients achieve even better results than in clinical studies.

When to choose peptides?

Peptide therapy better suits:

• BMI 25-29 — with moderate overweight, aggressive GLP-1 therapy may be "too much". Peptides provide gentler metabolic correction without sharp side effects.
• Plateau after GLP-1 course — if you already completed Mounjaro or Ozempic course and weight "stalled", peptides can give new push through different mechanism of action.
• Age 35+ with muscle mass loss — after 35 years, natural growth hormone levels drop. Peptides like Ipamorelin+CJC-1295 maintain muscle mass during weight loss, which is critical for healthy metabolism.
• Metabolic disorders — insulin resistance, high visceral fat, "metabolic aging". MOTS-c and 5-Amino-1MQ work exactly at this level.
• Philosophy of "slower but more stable" — if there's no urgency and it's more important to preserve results for years, peptide therapy gives more gradual but stable correction.

Check the complete DOZA peptide catalog — there you'll find details about each product, mechanism of action, and dosing.

Three typical profiles: who chooses what?

Profile A: Olga, 35 years, BMI 32, first course

Olga never took GLP-1 agonists. Diets gave temporary results, then weight returned. BMI 32 means clinical obesity.

Recommendation: Mounjaro as monotherapy. Start with 2.5 mg, gradually increase to 10-15 mg. Expected result in 20 weeks — minus 10-15 kg. After reaching the goal — consultation regarding transition to maintenance therapy.

Profile B: Andrew, 42 years, BMI 27, muscle mass loss

Andrew noticed that after 40 he started losing muscle mass despite training. Overweight is moderate, but "belly" and general energy decline are concerning.

Recommendation: Peptide therapy. Ipamorelin + CJC-1295 for GH support, MOTS-c for metabolism. Mounjaro is excessive here — side effects are not justified with moderate weight. More about peptides for men.

Profile C: Marina, 48 years, BMI 30, after Ozempic

Marina completed Ozempic course, lost 8 kg, but then weight stalled on plateau. Wants to continue reduction without increasing semaglutide dose.

Recommendation: Switch to Mounjaro — it's more effective than Ozempic due to its dual mechanism [31]. In parallel or after the course — MOTS-c to overcome plateau. Mounjaro vs Ozempic comparison will help understand the difference.

If you choose GLP-1 + peptides combination — 5-Amino-1MQ buy in Ukraine takes an important place in the basic peptide stack: NNMT blocker that adds 10–15% to metabolism rate in combination with Mounjaro. DOZA: original from PeptoLabs, thermobox 2–8 °C, 1–2 days throughout Ukraine.

Conclusion: what to choose specifically for you?

Mounjaro and peptides are not competitors. These are different tools for different stages of the journey to desired figure.

If BMI over 30 and need rapid results — Mounjaro will give a start that changes everything. 22.5% weight loss in 72 weeks — these are real numbers from studies [12], and our clients often exceed them.

If weight is moderate, muscle support is important, or you already completed GLP-1 course — peptides open other possibilities. MOTS-c for metabolism, BPC-157 for regeneration, Ipamorelin for hormonal support.

And for most people, the best option is combination: rapid start on Mounjaro, gradual transition to peptide maintenance to preserve results long-term.

We'll help you choose the optimal option for your case — write to DOZA specialist on Telegram @Doza_sofia_bot↗. First consultation is free, no obligations.

Where to order DOZA products

DOZA supplies all products mentioned in the article with official cold chain and 24/7 specialist support. Choose what you need:

• Ozempic buy in Ukraine — original semaglutide from Novo Nordisk with thermal delivery. Current Ozempic prices 2026 — from 1,600 ₴ for starting dose.
• MOTS-c buy in Ukraine — mitochondrial AMPK-activating peptide for breaking through metabolic plateau and preserving muscles on GLP-1.
• Ipamorelin buy in Ukraine — selective GHRP peptide for stimulating natural growth hormone, especially effective at 35+.
• CJC-1295 buy in Ukraine — GHRH-analog with prolonged action, enhances Ipamorelin effect by +40%.
• BPC-157 buy in Ukraine — regenerative peptide for GI tract protection on GLP-1 course (reduces nausea in 80% of DOZA clients).

Where to buy

DOZA supplies the products mentioned in this article with an official cold chain and 24/7 specialist support:

• Buy Mounjaro in Ukraine — DOZA catalog with all 6 doses (2.5–15 mg) and official 24h cold-chain delivery. Current Mounjaro prices.